Glioblastoma integrated preclinical report: five curated targets, 34 registry candidates through a three-stage sensor funnel, a PIK3CA docking pilot at sub-angstrom top-pose RMSD and a measured N-methyl-alpelisib design line

A preclinical research package for glioblastoma assembled by the HELIX Discovery engine on 2026-11-21. Every figure below is read back from the deposited artifacts, not retold from prose. Target selection (stage 1, 112 HTTP attempts, offline model_calls: 0). From the disease record MONDO_0018177 / MeSH D005909 the engine carried forward EGFR, PIK3CA, IDH1, MGMT and KDR as the working panel; FGFR1, PDGFRA and ITGAV passed the DepMap lineage-selectivity rule, and PIK3CA and EGFR were added on association grounds. Ten drug-target pairs were fixed in the run configuration (temozolomide-MGMT, lomustine-MGMT, bevacizumab-VEGFA, regorafenib-KDR, vorasidenib-IDH1, alpelisib-PIK3CA plus the EGFR, PTEN, TP53 and TERT reference arms) over cell lines U-87MG and T98G. Compound intake (stage 2, 197 HTTP attempts). The sensor funnel across ChEMBL, DGIdb, BindingDB, PharmacoDB, FDA and DrugComb routes produced 34 unique registry records; 18 structures were resolved to clean SMILES for chemistry. Chemistry (stage 3, 45 HTTP attempts). pKa and cLogD were computed with an RDKit worker for the full CNS MPO panel; no external model calls and no paid inference were used anywhere in the three stages. Docking pilot (PIK3CA, 4JPS). AutoDock-Vina via meeko, three seeds (1941 / 3347 / 5689): top-pose RMSD 0.87-0.88 A. Design line A (N-methyl-alpelisib) measured TPSA -8.79 A^2, H-bond donors 2 to 1, median amide N to Val851 backbone O distance 3.18 to 6.35 A, and median Vina score -8.31 against -9.91 for the reference. Live dossier run. A separate LIVE pass produced 10 target-drug dossiers with 370 HTTP attempts across 18 hosts; mode LIVE, model_calls: 0, cost_usd: 0.0. The "354 HTTP attempts" quoted in the PDF covers stages 1-3 only (112 + 197 + 45); the 370 in run_summary.json belongs to the dossier run. Both numbers are measured and refer to different passes. Boundaries. The novelty and selectivity scores in this package are NOT calibrated (calibrated: false in the run summary); nothing here is a clinical, diagnostic or therapeutic claim, and no compound in it has been tested experimentally by the author. This is a documented, reproducible research output with per-host request receipts, offered as a working example of an $0 instrumented discovery chain.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24424485
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Glioblastoma integrated preclinical report: five curated targets, 34 registry candidates through a three-stage sensor funnel, a PIK3CA docking pilot at sub-angstrom top-pose RMSD and a measured N-methyl-alpelisib design line

Dzianis Vashkevich
Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

Glioblastoma integrated preclinical report: five curated targets, 34 registry candidates through a three-stage sensor funnel, a PIK3CA docking pilot at sub-angstrom top-pose RMSD and a measured N-methyl-alpelisib design line

Dzianis Vashkevich
article en

Abstract

A preclinical research package for glioblastoma assembled by the HELIX Discovery engine on 2026-11-21. Every figure below is read back from the deposited artifacts, not retold from prose. Target selection (stage 1, 112 HTTP attempts, offline model_calls: 0). From the disease record MONDO_0018177 / MeSH D005909 the engine carried forward EGFR, PIK3CA, IDH1, MGMT and KDR as the working panel; FGFR1, PDGFRA and ITGAV passed the DepMap lineage-selectivity rule, and PIK3CA and EGFR were added on association grounds. Ten drug-target pairs were fixed in the run configuration (temozolomide-MGMT, lomustine-MGMT, bevacizumab-VEGFA, regorafenib-KDR, vorasidenib-IDH1, alpelisib-PIK3CA plus the EGFR, PTEN, TP53 and TERT reference arms) over cell lines U-87MG and T98G. Compound intake (stage 2, 197 HTTP attempts). The sensor funnel across ChEMBL, DGIdb, BindingDB, PharmacoDB, FDA and DrugComb routes produced 34 unique registry records; 18 structures were resolved to clean SMILES for chemistry. Chemistry (stage 3, 45 HTTP attempts). pKa and cLogD were computed with an RDKit worker for the full CNS MPO panel; no external model calls and no paid inference were used anywhere in the three stages. Docking pilot (PIK3CA, 4JPS). AutoDock-Vina via meeko, three seeds (1941 / 3347 / 5689): top-pose RMSD 0.87-0.88 A. Design line A (N-methyl-alpelisib) measured TPSA -8.79 A^2, H-bond donors 2 to 1, median amide N to Val851 backbone O distance 3.18 to 6.35 A, and median Vina score -8.31 against -9.91 for the reference. Live dossier run. A separate LIVE pass produced 10 target-drug dossiers with 370 HTTP attempts across 18 hosts; mode LIVE, model_calls: 0, cost_usd: 0.0. The "354 HTTP attempts" quoted in the PDF covers stages 1-3 only (112 + 197 + 45); the 370 in run_summary.json belongs to the dossier run. Both numbers are measured and refer to different passes. Boundaries. The novelty and selectivity scores in this package are NOT calibrated (calibrated: false in the run summary); nothing here is a clinical, diagnostic or therapeutic claim, and no compound in it has been tested experimentally by the author. This is a documented, reproducible research output with per-host request receipts, offered as a working example of an $0 instrumented discovery chain.

Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Glioblastoma integrated preclinical report: five curated targets, 34 registry candidates through a three-stage sensor funnel, a PIK3CA docking pilot at sub-angstrom top-pose RMSD and a measured N-methyl-alpelisib design line — Dzianis Vashkevich · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS